You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Allogeneic Stem Cell Transplant

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Liver Transplantation, Renal Failure Trial (Octreotide Acetate, Placebo)

Not yet recruiting
  • Liver Transplantation
  • Renal Failure
  • Octreotide Acetate
  • Placebo
  • (no location specified)
Jun 25, 2021

Skin Diseases Trial (Exposed to UV)

Not yet recruiting
  • Skin Diseases
  • Exposed to UV
  • (no location specified)
Mar 10, 2023

Cancer, Solid Tumor, Hematologic Malignancy Trial in Hangzhou (engineered red blood cell WTX212)

Recruiting
  • Cancer
  • +2 more
  • engineered red blood cell WTX212
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People'S Hospital
Jan 21, 2023

Carcinoma, Hepatocellular, Cirrhosis Trial in Italy (Liver transplantation)

Completed
  • Carcinoma, Hepatocellular
  • Cirrhosis
  • Liver transplantation
  • Bergamo, Italy
  • +9 more
Oct 4, 2021

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial (pembrolizumab, paclitaxel)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
May 12, 2022

HPV-unrelated Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (Palbociclib, Cetuximab)

Recruiting
  • HPV-unrelated Head and Neck Squamous Cell Carcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 7, 2022

FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at

Recruiting
  • Monkeypox
    • Antwerp, Belgium
      Institute of Tropical Medicine
    May 19, 2023

    Large-B-cell Diffuse Lymphoma, Chronic Lymphoid Leukemia Trial in Italy (Rituximab, Chemotherapy, Tenofovir alafenamide)

    Recruiting
    • Large-B-cell Diffuse Lymphoma
    • Chronic Lymphoid Leukemia
    • Roma, (rm), Italy
    • +30 more
    Jan 3, 2022

    Prognostic Value of CD318 in AML at Assiut University Hospital.

    Not yet recruiting
    • Acute Myeloid Leukemia
    • CD318
    • (no location specified)
    Jan 17, 2021

    CCND1 Gene Amplification, CCND2 Gene Amplification, CCND3 Gene Amplification Trial in United States (Docetaxel, Laboratory

    Completed
    Has Results
    • CCND1 Gene Amplification
    • +5 more
    • Birmingham, Alabama
    • +1064 more
    May 25, 2021

    Esophageal Squamous Carcinoma Trial in China (JMT101, Afatinib)

    Recruiting
    • Esophageal Squamous Carcinoma
    • Beijing, Beijing, China
    • +4 more
    Dec 18, 2021

    Extensive Stage Small Cell Lung Cancer Trial in Shanghai (HLX10, carboplatin and etoposide, )

    Active, not recruiting
    • Extensive Stage Small Cell Lung Cancer
    • Shanghai, China
    • +5 more
    Sep 28, 2022

    COVID-19 Trial (Recombinant two-component COVID-19 vaccine (CHO cell), Placebo)

    Recruiting
    • COVID-19
    • Part1:Recombinant two-component COVID-19 vaccine (CHO cell)
    • +3 more
    • Roxas City, Philippines
      The Health Centrum
    Sep 29, 2022

    Multiple Sclerosis, Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and

    Not yet recruiting
    • Multiple Sclerosis
    • Progressive Multifocal Leukoencephalopathy
    • 89 Zr-Df-crefmirlimab
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    May 13, 2023

    Frailty, Cirrhosis, Liver Transplant Trial in Chicago ("LIver FrailTy" intervention (LIFT), "Realistic Effort Action Planning"

    Recruiting
    • Frailty
    • +2 more
    • "LIver FrailTy" intervention (LIFT)
    • "Realistic Effort Action Planning" intervention (REAP)
    • Chicago, Illinois
      Northwestern Medicine
    Apr 6, 2021

    Acute Myeloid Leukemia Trial in Suzhou (anti-FLT3 CAR-T)

    Recruiting
    • Acute Myeloid Leukemia
    • anti-FLT3 CAR-T
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Dec 29, 2021

    Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

    Completed
    • Melanoma
    • +6 more
    • Combination of NKTR-214 + nivolumab
    • La Jolla, California
    • +57 more
    Jun 22, 2022

    Poliomyelitis Trial in Geelong, Melbourne (Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio), Inactivated

    Not yet recruiting
    • Poliomyelitis
    • Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio)
    • +3 more
    • Geelong, Victoria, Australia
    • +1 more
    Oct 30, 2023

    Lung Cancer Stage II Trial (Camrelizumab+ pemetrexed + platinum)

    Not yet recruiting
    • Lung Cancer Stage II
    • Camrelizumab+ pemetrexed + platinum
    • (no location specified)
    Jul 16, 2021

    Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 Trial in United States

    Recruiting
    • Metastatic Renal Cell Carcinoma
    • +3 more
    • Avelumab
    • +7 more
    • Danville, Illinois
    • +4 more
    Jul 29, 2022

    Spinal Cord Injury Cervical Trial in Badalona, A Coruña (WJ-MSC (XCEL-UMC-BETA), Placebo)

    Active, not recruiting
    • Spinal Cord Injury Cervical
    • WJ-MSC (XCEL-UMC-BETA)
    • Placebo
    • Badalona, Barcelona, Spain
    • +1 more
    Jul 5, 2022

    Follicular Lymphoma, Mantle Cell Lymphoma Trial in New York (Ribavirin)

    Terminated
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • New York, New York
      Weill Cornell Medicine
    Sep 20, 2021

    Acute Myeloid Leukemia, Lymphoma, Mantle-Cell Trial (PEP07)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Lymphoma, Mantle-Cell
    • (no location specified)
    Dec 22, 2022

    Paternal Age and Fetal Aneuploidy

    Active, not recruiting
    • Trisomy 21
    • Optimo prenatal screening test
    • Montréal, Quebec, Canada
      Clinique Ovo
    Aug 7, 2023

    Renal Cell Cancer, Melanoma, Non-Small-Cell Lung Cancer Trial in Duarte, Louisville, New York (PF-07263689, Sasanlimab)

    Active, not recruiting
    • Renal Cell Cancer
    • +9 more
    • PF-07263689
    • Sasanlimab
    • Duarte, California
    • +5 more
    Nov 8, 2022